Free Trial

Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Palisade Capital Management LP

Azenta logo with Medical background

Palisade Capital Management LP raised its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 7.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 868,324 shares of the company's stock after buying an additional 57,418 shares during the quarter. Palisade Capital Management LP owned approximately 1.90% of Azenta worth $30,079,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its stake in Azenta by 0.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock valued at $151,659,000 after acquiring an additional 26,929 shares during the last quarter. Conestoga Capital Advisors LLC increased its holdings in shares of Azenta by 21.4% in the first quarter. Conestoga Capital Advisors LLC now owns 1,915,556 shares of the company's stock valued at $66,355,000 after purchasing an additional 337,675 shares during the period. Schroder Investment Management Group raised its stake in shares of Azenta by 46.7% during the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after purchasing an additional 447,292 shares during the last quarter. Lord Abbett & CO. LLC purchased a new stake in shares of Azenta during the fourth quarter worth approximately $47,350,000. Finally, Federated Hermes Inc. raised its stake in shares of Azenta by 65.9% during the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock worth $38,109,000 after purchasing an additional 302,786 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analysts Set New Price Targets

Separately, Needham & Company LLC cut their price target on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th.

Check Out Our Latest Analysis on AZTA

Azenta Price Performance

Shares of AZTA stock traded down $1.42 during trading hours on Friday, reaching $31.43. 543,408 shares of the company's stock were exchanged, compared to its average volume of 735,375. The company has a market cap of $1.44 billion, a P/E ratio of -22.61 and a beta of 1.64. The company's 50 day moving average is $28.54 and its two-hundred day moving average is $37.59. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. The company's quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.06 EPS. As a group, analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines